SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

"What's Updog?" is a Community Led token.

UpDog

UpDog ($UPDOG.X) is trending, and the community is actively engaging in the classic "What's UpDog?" joke, driving much of the conversation. This meme coin on the Solana network, with locked liquidity and a dedicated community, is striving to be the top dog. Amidst the humor, some users are questioning the token's utility and suggesting that the trending status might be artificially driven.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The "crow with knife" ($CAW.X) crypto is trending as its community rallies behind the meme coin, emphasizing its multi-chain presence and deflationary mechanisms. Active discussions highlight the strength of the community and the potential for significant gains. The coin's presence on multiple chains like Solana, BSC, Cronos, and ETH (Base) is a key talking point.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MLTX is trending due to positive Phase 2 trial results for its hidradenitis suppurativa treatment, sonelokimab, generating significant community excitement. Discussions revolve around the drug's potential efficacy and a possible acquisition, with some speculating on buyout prices and comparing it to competitor data. The stock's high short interest and potential for a squeeze are also being actively discussed.

Meet Pandu — your AI friend who’s always by your side. Talk with him in real time through text or voice, share your thoughts, ask questions, or just enjoy a casual conversation. Whether you’re looking for advice, company, or simply someone to listen, Pandu is here as a true companion you can connect with anytime.  Pandu unites real-time conversation, creative generation, and future-ready AI systems — all powered by next-gen technology.

Pandu Pandas

Pandu Pandas ($PANDU.X) is trending, with community members highlighting its recent listing on MEXC and drawing comparisons to other successful meme coins. Bullish sentiment is fueled by perceived solid fundamentals and the project's NFT ranking, with many urging others to research the token. Some users are also discussing preferred wallets for holding $PANDU.X.

BRETT the dancer, gamer, and cultural icon of BASE chain (some like to call me the PEPE of BASE).

Brett

BRETT.X is trending as the community discusses its potential, particularly within the Base ecosystem, while comparing it to other meme coins like TOSHI.X and JTRAMBO. Bullish sentiment is fueled by technical analysis suggesting upside continuation and speculation around a possible Binance or Coinbase listing. Some traders are suggesting it might be time to accumulate $BRETT.X

A composable native asset bridge with unified liquidity and instant guaranteed finality

Stargate

Stargate is trending due to news of LayerZero's acquisition, with a community vote passing for STG holders to convert to ZRO. There's also buzz around the token's role in bridging and burning $CAW.X, with some users highlighting Hyperliquid's new direct deposit feature via Stargate.

LayerZero

LayerZero is trending due to its role in enabling cross-chain functionality, particularly with meme coin $CAW.X. The community is highlighting $CAW.X as the first Cronos project to utilize LayerZero, similar to how $USDC.X and $PEPE.X use it, expressing bullish sentiment and discussing its multichain capabilities.

WeRide, Inc. is a holding company, which engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers, and related sensor suites. The company was founded by Tony Xu Han and Yan Li on March 13, 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide ($WRD) is trending due to positive Q2 earnings, highlighting significant robotaxi revenue growth and expanded global operations, including a new permit in Saudi Arabia. The community is discussing the partnership with Bosch for mass production of ADAS systems and upcoming collaboration with UBER and GRAB, though some express frustration with the stock's price action despite the positive news.

BlackRock Institutional Trust Company N.A. - iShares Gold Trust Micro

iShares Gold Trust Micro ETF

IAUM is trending as gold prices rally, driven by factors like recession fears and geopolitical uncertainty, leading to discussions about gold's role as a safe-haven asset. Community members are actively weighing IAUM against other gold ETFs and physical gold, considering factors like fees, liquidity, and tax implications for long-term holdings. Some analysts predict further gains for gold, citing potential shifts in investment from U.S. Treasuries.

Green Satoshi Token

Green Satoshi Token is trending as community members anticipate a potential pump, citing increasing volume and technical indicators that suggest a possible breakout. Some traders are drawing comparisons to previous rallies, while others urge patience as they await a significant move. Discussions also mention the broader context of Solana coins potentially rising, adding to the speculative buzz around GSTSOL.X.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FDA Accepts Corcept's NDA for Relacorilant in Ovarian Cancer

CORT's NDA for relacorilant in platinum-resistant ovarian cancer gains FDA acceptance, with a decision expected by July 2026.

Can Korlym Drive Corcept's Growth Through the Rest of 2025?

CORT projects $850-$900M in 2025 revenues as Korlym sales rise and relacorilant nears an FDA decision for Cushing's syndrome.

Corcept Shares Rise 39.6% in YTD: How Should You Play the Stock?

CORT's stock is up 39.6% year to date as relacorilant nears FDA approval for Cushing's syndrome and expands into cancer studies.

CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down

Corcept beats second-quarter earnings forecasts but misses the same for revenues. The company trims its 2025 revenue outlook.

Corcept Therapeutics (CORT) Tops Q2 Earnings Estimates

Corcept (CORT) delivered earnings and revenue surprises of +26.09% and -4.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Madrigal (MDGL) Moves 10.9% Higher: Will This Strength Last?

Madrigal (MDGL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Corcept Seeks FDA Approval for Relacorilant in Ovarian Cancer

CORT's relacorilant combo targets platinum-resistant ovarian cancer in new NDA, backed by positive ROSELLA study data.

Should Invesco S&P SmallCap Momentum ETF (XSMO) Be on Your Investing Radar?

Aurinia (AUPH) Surges 7.5%: Is This an Indication of Further Gains?

Aurinia (AUPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Should JPMorgan Diversified Return U.S. Small Cap Equity ETF (JPSE) Be on Your Investing Radar?

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$0.17	--	--	N/A
Q2 '25	$0.19	$0.29	54.67%	BEAT
Q1 '25	$0.14	$0.17	19.30%	BEAT
Q4 '24	$0.43	$0.26	-39.00%	MISSED
Q3 '24	$0.28	$0.41	45.42%	BEAT

CORT
Corcept Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest CORT News

CORT Corcept Therapeutics Inc